Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 1, 2004, Pages 118-

  Aihara, Y ^a   Ito, S ^a   Kobayashi, Y ^a   Aihara, M ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Azithromycin; Cytokine; Herpes simplex virus; Reactivation; Stevens Johnson syndrome

Indexed keywords

ACICLOVIR; AZITHROMYCIN; BETAMETHASONE; BETAMIPRON; CEFAZOLIN; PANIPENEM; STEROID; ULINASTATIN;

ANAMNESIS; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; CONJUNCTIVITIS; DISEASE COURSE; DRUG ERUPTION; ERYTHEMA; HERPES; HERPES SIMPLEX VIRUS; HUMAN; LABORATORY TEST; MALE; MOUTH DISEASE; MOUTH ULCER; PAIN; PATCH TEST; PENIS DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; VIRUS ACTIVATION;

EID: 0842308844     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1398-9995.2003.00336.x     Document Type: Article

References (2)

1. YAWALKAR N, REIMERS A, HARI Y, HUNZIKER T, GERBER H, MULLER U et al. Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells. Dermatol 1999;199:25-30.
2. GARCIA-DOVAL I, LECLEACH L, BOCQUET H, OTERO XL, ROUJEAU JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000;136:323-327.